188 related articles for article (PubMed ID: 3124643)
1. Successful vaccination against murine Schistosoma mansoni infection with a purified 12 Kd Fasciola hepatica cross-reactive antigen.
Hillyer GV; García Rosa MI; Alicea H; Hernandez A
Am J Trop Med Hyg; 1988 Jan; 38(1):103-10. PubMed ID: 3124643
[TBL] [Abstract][Full Text] [Related]
2. Acquired immunity in schistosomiasis with purified Fasciola hepatica cross-reactive antigens.
Hillyer GV; Soler de Galanes M; García Rosa MI; Montealegre F
Vet Parasitol; 1988 Sep; 29(2-3):265-80. PubMed ID: 3144081
[TBL] [Abstract][Full Text] [Related]
3. The antigens of Paragonimus westermani, Schistosoma mansoni, and Fasciola hepatica adult worms. Evidence for the presence of cross-reactive antigens and for cross-protection to Schistosoma mansoni infection using antigens of Paragonimus westermani.
Hillyer GV; Serrano AE
Am J Trop Med Hyg; 1983 Mar; 32(2):350-8. PubMed ID: 6404188
[TBL] [Abstract][Full Text] [Related]
4. Induction of immunity in mice to Fasciola hepatica with a Fasciola/Schistosoma cross-reactive defined immunity antigen.
Hillyer GV
Am J Trop Med Hyg; 1985 Nov; 34(6):1127-31. PubMed ID: 3834796
[TBL] [Abstract][Full Text] [Related]
5. Isolation and partial characterization of an antigen shared between Schistosoma mansoni, Fasciola hepatica, and Biomphalaria glabrata.
Rasmussen KR; Hillyer GV; Kemp WM
J Parasitol; 1985 Dec; 71(6):792-8. PubMed ID: 2419536
[TBL] [Abstract][Full Text] [Related]
6. Fasciola hepatica and Schistosoma mansoni: immunofluorescent antigen localization and cross-reactivity.
Hanna RE; Hillyer GV
Exp Parasitol; 1984 Feb; 57(1):1-14. PubMed ID: 6198200
[TBL] [Abstract][Full Text] [Related]
7. Cross protection in infections due to Schistosoma mansoni using tegument antigens of Fasciola hepatica.
Hillyer GV; Serrano AE
J Infect Dis; 1982 May; 145(5):728-32. PubMed ID: 7077096
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a major Schistosoma mansoni glycoprotein antigen cross-reactive with Fasciola hepatica.
Aronstein WS; Dalton JP; Weiss JB; Strand M
Am J Trop Med Hyg; 1985 Sep; 34(5):879-88. PubMed ID: 4037178
[TBL] [Abstract][Full Text] [Related]
9. Comparison of purified 12 kDa and recombinant 15 kDa Fasciola hepatica antigens related to a Schistosoma mansoni fatty acid binding protein.
Hillyer GV
Mem Inst Oswaldo Cruz; 1995; 90(2):249-53. PubMed ID: 8531666
[TBL] [Abstract][Full Text] [Related]
10. A Schistosoma mansoni surface glycoprotein cross-reactive with a T1 antigen of Fasciola hepatica.
Aronstein WS; Dalton JP; Strand M
Am J Trop Med Hyg; 1985 Sep; 34(5):889-97. PubMed ID: 4037179
[TBL] [Abstract][Full Text] [Related]
11. Fasciola hepatica: host responders and nonresponders to parasite glutathione S-transferase.
Hillyer GV; Soler de Galanes M; Battisti G
Exp Parasitol; 1992 Sep; 75(2):176-86. PubMed ID: 1516666
[TBL] [Abstract][Full Text] [Related]
12. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
[TBL] [Abstract][Full Text] [Related]
13. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine.
Tendler M; Brito CA; Vilar MM; Serra-Freire N; Diogo CM; Almeida MS; Delbem AC; Da Silva JF; Savino W; Garratt RC; Katz N; Simpson AS
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):269-73. PubMed ID: 8552619
[TBL] [Abstract][Full Text] [Related]
14. Isolation and partial characterization of shared antigens of Biomphalaria glabrata and Schistosoma mansoni and their evaluation by the ELISA and the EITB.
Rivera-Marrero CA; Hillyer GV
J Parasitol; 1985 Oct; 71(5):547-55. PubMed ID: 3932633
[TBL] [Abstract][Full Text] [Related]
15. Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?
Tendler M; Vilar MM; Brito CA; Freire NM; Katz N; Simpson A
Mem Inst Oswaldo Cruz; 1995; 90(2):255-6. PubMed ID: 8531667
[TBL] [Abstract][Full Text] [Related]
16. Immunity of schistosomes using heterologous trematode antigens--a review.
Hillyer GV
Vet Parasitol; 1984 Jun; 14(3-4):263-83. PubMed ID: 6382782
[TBL] [Abstract][Full Text] [Related]
17. Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family.
Torres D; Espino AM
Infect Immun; 2006 Aug; 74(8):4932-8. PubMed ID: 16861685
[TBL] [Abstract][Full Text] [Related]
18. Reevaluation of the potential of Fasciola hepatica antigens for immunization against Schistosoma mansoni infection.
Ford MJ; Taylor MG; Bickle QD
Parasitology; 1987 Apr; 94 ( Pt 2)():327-36. PubMed ID: 3108833
[TBL] [Abstract][Full Text] [Related]
19. Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14.
Almeida MS; Torloni H; Lee-Ho P; Vilar MM; Thaumaturgo N; Simpson AJ; Tendler M
Parasite Immunol; 2003 Mar; 25(3):135-7. PubMed ID: 12911521
[TBL] [Abstract][Full Text] [Related]
20. Isolation of potential serodiagnostic Fasciola hepatica antigens by electroelution from polyacrylamide gels.
Santiago N; Hillyer GV
Am J Trop Med Hyg; 1986 Nov; 35(6):1210-7. PubMed ID: 3538921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
